Boston Scientific Corporation BSX

43.92 (0.76) (1.70%) as of 25 Sep
Market cap
$64.7B
P/E
17.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
48.65 70.89 54.06 102.24 61.57 0.00 13.38 29.21 316.00 84.15
P/S ratio
7.03 7.85 5.90 5.19 5.08 5.14 5.86 4.97 3.83 3.54
P/FCF ratio
38.59 49.69 46.90 69.28 45.43 44.52 45.53 6,100.57 31.29 35.57
P/Operating CF
103.49 90.27 87.82 81.56 126.40 75.68 90.93 2,568.66 50.64 43.94
P/B ratio
5.77 5.97 4.30 3.75 3.63 3.32 4.53 5.59 4.94 4.41
EV/Sales
7.50 8.47 6.48 5.82 5.68 5.89 6.77 5.67 4.43 4.17
EV/EBITDA
29.97 33.28 25.65 25.33 25.39 36.99 47.93 37.00 31.18 78.28
EV/FCF
41.18 53.60 51.49 77.71 50.80 51.00 52.62 6,964.32 36.19 41.91
Current Ratio
1.62 1.08 1.32 1.51 1.48 1.82 0.97 0.76 0.68 0.90
Net Debt/EBITDA
1.88 2.43 2.29 2.75 2.68 4.70 3.72 2.84 2.54 4.15
Debt/Equity
0.47 0.49 0.47 0.51 0.55 0.60 0.72 0.81 0.80 0.81
ROE
12.47% 8.92% 8.46% 3.75% 6.17% (0.79%) 41.59% 21.24% 1.51% 5.32%
ROA
6.98% 4.97% 4.64% 1.98% 3.13% (0.37%) 18.23% 8.35% 0.56% 1.92%
ROIC
6.65% 5.04% 5.27% 4.02% 3.15% (0.22%) 4.01% 6.02% 6.46% 2.32%
Return on Tangible Assets
39.21% 48.57% 35.36% 14.58% 22.93% (2.26%) 245.82% 318.29% (77.04%) 27.07%
Average Days of Receivables
53.20 55.75 57.11 56.70 54.59 56.37 62.15 59.75 62.45 64.07
Earnings Yield
2.06% 1.41% 1.85% 0.98% 1.62% (0.34%) 7.47% 3.42% 0.32% 1.19%
Free Cash Flow Yield
2.59% 2.01% 2.13% 1.44% 2.20% 2.25% 2.20% 0.02% 3.20% 2.81%
Free Cash Flow per Share
2.47 1.80 1.23 0.66 0.94 0.81 0.99 0.01 0.81 0.62
Book value per Share
16.53 14.95 13.44 12.28 11.69 10.82 9.97 6.32 5.12 4.96
Free Cash Flow
3,658.00 2,645.00 1,792.00 950.00 1,330.00 1,144.00 1,382.00 8.00 1,107.00 835.00
EV/EBIT
41.70 54.42 39.38 44.82 56.39 0.00 47.93 37.00 31.18 78.28
Other line items

Show all line items

Columns are period end dates